10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 359,284 | 311,764 | 327,379 | 334,820 | 222,379 |
| Marketable Securities | 29,411 | 45,643 | 65,506 | 85,970 | 210,238 |
| Receivables | 114,832 | 103,847 | 87,685 | 77,940 | 104,211 |
| Inventories | 73,706 | 80,917 | 83,687 | 82,307 | 81,629 |
| TOTAL | $596,022 | $562,348 | $582,940 | $601,894 | $635,035 |
| Non-Current Assets | |||||
| PPE Net | 279,571 | 285,008 | 284,913 | 292,106 | 289,328 |
| Intangibles | 21,127 | 26,344 | 26,801 | 27,459 | 27,369 |
| Other Non-Current Assets | 68,423 | 74,840 | 94,984 | 92,571 | 77,248 |
| TOTAL | $369,121 | $386,192 | $406,698 | $412,136 | $393,945 |
| Total Assets | $965,143 | $948,540 | $989,638 | $1,014,030 | $1,028,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,738 | 18,836 | 23,124 | 29,317 | 21,599 |
| Accrued Expenses | 86,753 | 64,733 | 56,460 | 64,960 | 92,454 |
| TOTAL | $127,162 | $104,717 | $98,087 | $112,006 | $130,957 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,150 | 11,143 | 9,217 | 8,530 | 7,867 |
| Other Non-Current Liabilities | 88,124 | 98,607 | 98,250 | 99,639 | 89,115 |
| TOTAL | $96,938 | $98,607 | $98,250 | $99,639 | $92,280 |
| Total Liabilities | $224,100 | $203,324 | $196,337 | $211,645 | $223,237 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,167 | 118,209 | 117,418 | 116,192 | 115,357 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,284,420 | -1,235,468 | -1,142,482 | -1,080,068 | -1,029,321 |
| Other shareholders' equity | -429 | -677 | -969 | -1,479 | -4,335 |
| TOTAL | $741,043 | $745,216 | $793,301 | $802,385 | $805,743 |
| Total Liabilities And Equity | $965,143 | $948,540 | $989,638 | $1,014,030 | $1,028,980 |